Success Stories: EB-1A Approved for Cardiovascular Fellow in Ohio in the Field of Cardiology
Client’s Testimonial:
Your firm has been very prompt and efficient and we greatly appreciate your help.
On March 4, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Cardiovascular Fellow in the Field of Cardiology (Approval Notice)
Position at the Time of Case Filing: Cardiovascular Fellow
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Ohio
Approval Notice Date: March 4th, 2015
Processing Time: 5 Months, 1 Day
For this case we worked with a cardiologist from India with a specialized focus on atrial fibrillation, cardiac electrophysiology, left atrial appendage closure, cardiac imaging, heart failure, and the use of YouTube in relation to learning CPR. His highly prolific career thus far had produced 32 peer-reviewed scientific articles and numerous presentations at national and international conferences, and he had been cited at least 176 times, primarily by independent researchers at prominent and leading institutions and organizations worldwide. This remarkable citation record clearly indicates the major significance of our client’s work. He had also reviewed at least 2 manuscripts for a distinctive, internationally-circulated journal. It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Cardiology, and that his continued research would substantially and prospectively benefit the United States. An independent recommender affirmed the superior nature of our client’s expertise: “Overall, [Client] is a special researcher who has used his expertise in various areas of the field. He is a top researcher whose scientific acumen has helped him to excel in investigating and discovering important clinical information. I believe it is necessary for a brilliant scientist like [Client] to be able to continue to research on clinical treatments and technologies for illnesses and I am certain that his future career will continue to produce achievements with international significance.” With the proof and documentation that we provided, his case was approved in five months and one day.